Guoqiang Zhou
Guoqiang Zhou publishes mostly in Organic Chemistry, Biomedical Engineering and Materials Chemistry, on topics such as Nanoplatforms for cancer theranostics, Bone Tissue Engineering Materials and Electrospun Nanofibers in Biomedical Applications.
- World rank
- #758,848 of 7,710,434 ranked researchers
- Rank in China
- #101,470 of 978,568
- Works
- 177
- Citations
- 5.6k
- Citations per work
- 31.7
What does Guoqiang Zhou research?
Guoqiang Zhou's work is mostly in Materials Science (17%), Chemistry (15%), Engineering (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences8346.8%
- Materials Science3017.0%
- Chemistry2715.4%
- Engineering2514.4%
- Everything else7843.8%
- Life Sciences105.4%
- Health Sciences74.0%
- Medicine74.0%
- 1Organic Chemistry15% of their works
- 2Biomedical Engineering14% of their works
- 3Materials Chemistry10% of their works
- 4Biomaterials7% of their works
- 5Molecular Biology5% of their works
- 6Infectious Diseases4% of their works
Research topics
- Nanoplatforms for cancer theranostics
- Bone Tissue Engineering Materials
- Electrospun Nanofibers in Biomedical Applications
- Advanced Nanomaterials in Catalysis
- Graphene and Nanomaterials Applications
- Advanced Cellulose Research Studies
- Nanoparticles: synthesis and applications
- Metal complexes synthesis and properties
Which keywords describe Guoqiang Zhou's research?
The keywords of their largest research topics: Biomedical Applications, Tissue Engineering, Drug Delivery, Nanoparticles, Nanomaterials, Toxicity, Photothermal Therapy and Reactive Oxygen Species.
- Silver
- Nanocellulose
- Cellulose Nanocrystals
- Graphene
- Peroxidase-Like Activity
- Scaffolds
- Electrospinning
- Reactive Oxygen Species
- Toxicity
- Nanoparticles
- Tissue Engineering
- Biomedical Applications
- Drug Delivery
- Nanomaterials
- Photothermal Therapy
- Biomaterials
- Nanofibers
- Nanozymes
- Antibacterial Activity
- Antimicrobial
- Cisplatin Resistance
- Platinum-Based Drugs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Biomedical Applications474 topics
- Tissue Engineering393 topics
- Drug Delivery252 topics
- Nanoparticles252 topics
- Nanomaterials212 topics
- Toxicity212 topics
- Photothermal Therapy151 topic
- Reactive Oxygen Species151 topic
- Biomaterials141 topic
- Electrospinning141 topic
- Nanofibers141 topic
- Scaffolds141 topic
- Nanozymes121 topic
- Peroxidase-Like Activity121 topic
- Antibacterial Activity111 topic
- Graphene111 topic
- Antimicrobial101 topic
- Cellulose Nanocrystals101 topic
- Cisplatin Resistance101 topic
- Nanocellulose101 topic
- Platinum-Based Drugs101 topic
- Silver101 topic
Where does Guoqiang Zhou work?
Guoqiang Zhou's main affiliation in the publication record is Hebei University, China.
How many publications and citations does Guoqiang Zhou have?
OpenAlex counts 177 works and 5,617 citations for Guoqiang Zhou, an h-index of 41, ranking #758,848 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Guoqiang Zhou
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Guoqiang Zhou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.